BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 31593975)

  • 1. The evolving treatment landscape of chronic lymphocytic leukemia.
    Schiattone L; Ghia P; Scarfò L
    Curr Opin Oncol; 2019 Nov; 31(6):568-573. PubMed ID: 31593975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BTK Inhibitors in Chronic Lymphocytic Leukemia.
    Gaballa S; Pinilla-Ibarz J
    Curr Hematol Malig Rep; 2021 Oct; 16(5):422-432. PubMed ID: 34599723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted therapies for CLL: Practical issues with the changing treatment paradigm.
    Jain N; O'Brien S
    Blood Rev; 2016 May; 30(3):233-44. PubMed ID: 26776345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL).
    Odetola O; Ma S
    Curr Hematol Malig Rep; 2023 Oct; 18(5):130-143. PubMed ID: 37278884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frontline Therapy of Chronic Lymphocytic Leukemia: Changing Treatment Paradigm.
    Sengar M; Jain H; Rajendra A; Rengaraj K; Thorat J
    Curr Hematol Malig Rep; 2020 Jun; 15(3):168-176. PubMed ID: 32542586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Treatment Options for Newly-Diagnosed and Relapsed Chronic Lymphocytic Leukemia.
    Iskierka-Jażdżewska E; Obracaj A; Urbaniak M; Robak T
    Curr Treat Options Oncol; 2022 Jun; 23(6):775-795. PubMed ID: 35357653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revolution of Chronic Lymphocytic Leukemia Therapy: the Chemo-Free Treatment Paradigm.
    Scheffold A; Stilgenbauer S
    Curr Oncol Rep; 2020 Feb; 22(2):16. PubMed ID: 32025827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Treatment of Chronic Lymphocytic Leukemia: The Diminishing Role of Chemoimmunotherapy.
    Roeker LE; Thompson M; Mato AR
    Drugs; 2022 Feb; 82(2):133-143. PubMed ID: 34932207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frontline Treatment for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Targeted Therapy vs. Chemoimmunotherapy.
    Small S; Ma S
    Curr Hematol Malig Rep; 2021 Aug; 16(4):325-335. PubMed ID: 34021874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment strategies for a rapidly evolving landscape in chronic lymphocytic leukemia management.
    Eyre TA; Hori S; Munir T
    Hematol Oncol; 2022 Apr; 40(2):129-159. PubMed ID: 34713475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Therapies in Chronic Lymphocytic Leukemia: A Rapidly Changing Landscape.
    Iovino L; Shadman M
    Curr Treat Options Oncol; 2020 Mar; 21(4):24. PubMed ID: 32170458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Therapies in CLL: Monotherapy Versus Combination Approaches.
    Khan M; Siddiqi T
    Curr Hematol Malig Rep; 2018 Dec; 13(6):525-533. PubMed ID: 30535947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A network meta-analysis of maintenance therapy in chronic lymphocytic leukemia.
    Lee CH; Chen PH; Lin C; Wang CY; Ho CL
    PLoS One; 2020; 15(1):e0226879. PubMed ID: 31995577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemotherapy-free treatment of chronic lymphocytic leukemia?].
    Wendtner CM
    Dtsch Med Wochenschr; 2013 Oct; 138(41):2104-6. PubMed ID: 24085367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody therapy alone and in combination with targeted drugs in chronic lymphocytic leukemia.
    Robak T; Blonski JZ; Robak P
    Semin Oncol; 2016 Apr; 43(2):280-90. PubMed ID: 27040707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current perspectives on the role of chemotherapy in chronic lymphocytic leukemia.
    Wendtner CM; Gregor M
    Leuk Lymphoma; 2018 Feb; 59(2):300-310. PubMed ID: 28565930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is There a Role for Chemotherapy in the Era of Targeted Therapies?
    Lee JC; Lamanna N
    Curr Hematol Malig Rep; 2020 Apr; 15(2):72-82. PubMed ID: 32107713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in the Era of Targeted Therapies.
    Rainone M; Siddiqi T
    Curr Hematol Malig Rep; 2022 Feb; 17(1):39-45. PubMed ID: 35028825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Treatment of Refractory/Relapsed Chronic Lymphocytic Leukemia: A Focus on Novel Drugs.
    Smolewski P; Robak T
    Acta Haematol; 2021; 144(4):365-379. PubMed ID: 33238270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic lymphocytic leukemia therapy: new targeted therapies on the way.
    Vitale C; Burger JA
    Expert Opin Pharmacother; 2016 Jun; 17(8):1077-89. PubMed ID: 26988407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.